Energy Metabolism
203 studies in the atlas
Altered energy metabolism is a candidate mechanism under active investigation in ME/CFS research. Studies report signals suggestive of impaired cellular energy production, altered metabolomics profiles, and elevated oxidative stress markers in patient populations. Metabolomics analyses have identified differences in metabolites associated with the citric acid cycle and amino acid metabolism, though findings are not uniform across cohorts and a specific mitochondrial mechanism has not been established. Cellular energy stress may contribute to the reduced functional capacity seen in ME/CFS; direct mechanistic proof for post-exertional malaise has not been demonstrated.
What we know
- Naviaux et al. (2016) identified a hypometabolic state in ME/CFS patients using broad metabolomic profiling
- Multiple independent studies have reported altered metabolite levels, though specific findings vary across cohorts
- Signals suggestive of impaired cellular energy production have been reported, including reduced oxidative phosphorylation in some studies, but a specific mitochondrial mechanism has not been established
- Metabolic differences appear to worsen after exertion in several studies, a pattern consistent with PEM
What remains uncertain
- Whether altered energy metabolism is a primary cause or a consequence of upstream immune or neurological processes
- Mitochondrial impairment has been proposed and partially supported, but the evidence is heterogeneous and a specific mechanism has not been established
- The relationship between metabolic findings and specific symptoms is not well mapped
- Whether metabolic subtypes exist that respond to different interventions
What is emerging
- Whether metabolomic profiles can serve as diagnostic biomarkers
- Whether targeted metabolic interventions (e.g., oxaloacetate, NAD+ precursors) have measurable benefit
- The full extent of metabolic overlap between ME/CFS and Long COVID
- How metabolic impairment relates to the exercise intolerance demonstrated in CPET studies
Start here
Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis.
Jinushi, Ryuhei, Masuda, Sakue, Tanisaka, Yuki et al.·Journal of translational medicine·2023
This review combined results from seven studies comparing a chemical in the blood called acylcarnitine between people with ME/CFS and healthy people. Researchers found that people with ME/CFS have significantly lower levels of this chemical. These lower levels might one day help doctors diagnose ME/CFS, though more research is needed before it can be used as a reliable test.
Research Momentum
203 publications over 36 years. Recent trend: steady (14/year over the last 3 years).
Top Studies
60 of 203, sorted by review status and evidence level
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.
2024 · ModerateComparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis.
2023 · ModerateCoenzyme Q10: Clinical Applications beyond Cardiovascular Diseases.
2021 · PreliminaryA systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome.
2021 · Preliminary[Myalgic encephalomyelitis or chronic fatigue syndrome].
2019 · ModerateMyalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities.
2019 · PreliminaryMyalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.
2018 · ModerateChronic fatigue syndrome: a personalized integrative medicine approach.
2014 · PreliminaryMetabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors.
2026 · PreliminaryUnderstanding the kynurenine pathway: A narrative review on its impact across chronic pain conditions.
2024 · ModerateInduced pluripotent stem cells as suitable sensors for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome.
2021 · PreliminaryDiagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome.
2021 · PreliminaryExamining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review.
2017 · PreliminaryPesticides and human chronic diseases: evidences, mechanisms, and perspectives.
2013 · PreliminaryRESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
2024 · ModerateMetabolic features of chronic fatigue syndrome
2016 · n=84 · ModerateSupplementation with Guanidinoacetic Acid in Women with Chronic Fatigue Syndrome.
2016 · PreliminaryDoes oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?
2015 · ModerateAmantadine and L-carnitine treatment of Chronic Fatigue Syndrome.
1997 · PreliminaryAI-driven multi-omics modeling of myalgic encephalomyelitis/chronic fatigue syndrome.
2025 · ModerateCirculating Levels of SMPDL3B Define Metabolic Endophenotypes and Subclinical Kidney Alterations in Myalgic Encephalomyelitis.
2025 · ModerateAlterations in gut microbiota and associated metabolites in patients with chronic fatigue syndrome.
2025 · ModerateLeveraging Explainable Automated Machine Learning (AutoML) and Metabolomics for Robust Diagnosis and Pathophysiological Insights in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
2025 · ModerateUntargeted Metabolomics and Quantitative Analysis of Tryptophan Metabolites in Myalgic Encephalomyelitis Patients and Healthy Volunteers: A Comparative Study Using High-Resolution Mass Spectrometry.
2024 · PreliminaryAssociation between fatigue, peripheral serotonin, and L-carnitine in hypothyroidism and in chronic fatigue syndrome.
2024 · PreliminaryPlasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome.
2022 · ModerateA map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
2021 · ModerateSex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.
2021 · ModerateMetabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies.
2020 · ModerateDeep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population.
2020 · PreliminaryComprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids.
2020 · PreliminaryChanges in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.
2020 · ModerateElevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome.
2019 · ModerateMtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants.
2019 · PreliminaryLow omega-3 index and polyunsaturated fatty acid status in patients with chronic fatigue syndrome/myalgic encephalomyelitis.
2018 · PreliminaryChronic fatigue syndrome patients have alterations in their oral microbiome composition and function.
2018 · PreliminaryHigher Prevalence of "Low T3 Syndrome" in Patients With Chronic Fatigue Syndrome: A Case-Control Study.
2018 · PreliminaryEvidence of mitochondrial dysfunction and impaired redox signalling in a subgroup of patients with myalgic encephalomyelitis/chronic fatigue syndrome
2017 · n=25 · PreliminaryMetabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.
2017 · PreliminaryFecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
2017 · ModerateClinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.
2017 · ModerateGenetic evaluation of AMPD1, CPT2, and PGYM metabolic enzymes in patients with chronic fatigue syndrome.
2016 · WeakIndex markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles.
2016 · PreliminaryMitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.
2016 · PreliminaryAssociation of mitochondrial DNA variants with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) symptoms.
2016 · PreliminaryMitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
2012 · PreliminaryIncreased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.
2012 · ModerateThe assessment of the energy metabolism in patients with chronic fatigue syndrome by serum fluorescence emission.
2012 · PreliminaryMitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome.
2011 · ModerateLong-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity.
2011 · PreliminaryChronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia.
2010 · ModeratePhysiological cost of walking in those with chronic fatigue syndrome (CFS): a case-control study.
2009 · ModerateIncreased d-lactic Acid intestinal bacteria in patients with chronic fatigue syndrome.
2009 · PreliminaryChronic fatigue syndrome and mitochondrial dysfunction.
2009 · PreliminaryVisible and near-infrared spectral changes in the thumb of patients with chronic fatigue syndrome.
2009 · PreliminaryTranscription profile analysis of vastus lateralis muscle from patients with chronic fatigue syndrome.
2009 · PreliminaryHematologic and urinary excretion anomalies in patients with chronic fatigue syndrome.
2007 · ModerateAllostatic load is associated with symptoms in chronic fatigue syndrome patients.
2006 · PreliminaryUrinary and plasma organic acids and amino acids in chronic fatigue syndrome.
2005 · PreliminaryContribute
Private, reviewed by a human. Not a public comment thread.